Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03370367
Brief Title: Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer

First Submitted : December 7, 2017
First Submitted that Met QC Criteria : December 11, 2017
First Posted : December 12, 2017

Last Update Submitted that Met QC Criteria : September 12, 2019
Last Update Posted : September 16, 2019